JAC Advance Access originally published online on May 4, 2007
Journal of Antimicrobial Chemotherapy 2007 60(1):176-177; doi:10.1093/jac/dkm132
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Correspondence |
Triclosan resistance in methicillin-resistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antisepticsauthors' response
Biomaterials-Related Infection Group, Division of Orthopaedic and Accident Surgery, School of Medical and Surgical Sciences, C Floor West Block, Queens Medical Centre, University Hospitals Nottingham, Nottingham NG7 2UH, UK
* Corresponding author. Tel: +44-115-82-31115; Fax: +44-115-82-31118; E-mail: roger.bayston@nottingham.ac.uk
Keywords: SCVs , S. aureus , MRSA , antimicrobial biomaterials
| The first 10% of the full text of this article appears below. |
Sir,
We welcome the opportunity to reply to the comments by Seaman et al.1 on our recent article.2 First, they say that we recognize, as others have done, ... the potential role of triclosan in [small colony variant (SCV)] generation. In fact, apart from the parallel publication by Seaman et al.,3 we know
Transparency declarations
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. T. Tsuji, C. von Eiff, P. A. Kelchlin, A. Forrest, and P. F. Smith Attenuated Vancomycin Bactericidal Activity against Staphylococcus aureus hemB Mutants Expressing the Small-Colony-Variant Phenotype Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1533 - 1537. [Abstract] [Full Text] [PDF] |
||||
